Why @BioProtocol matters 🧠
→ It manages AUM + POL
→ Liquidity is optimized
→ Fees fund long-term growth
Not just a launchpad. A funding engine for science.
WENDEV IS OFFICIALLY LIVE!
The FIRST launchpad that pays YOU to trade. Incase you've missed some key points👇
✅ 85% of all fees generated back to Traders, Creators, and Referrals
✅ All rewards claimable anytime via WENDEV dashboards
✅ Partnership Program - join Discord to learn more
✅ Early Q1 2026 $WENDEV airdrop
✅ Powered by @RaydiumProtocol
REWARDS WITH EVERY CLICK - LAUNCH NOW https://t.co/lwyZV2xKGs
The first leaderboard of the meme economy is live.
If you’ve been diamond-handing, check your score.
If you haven't, earn it.
→ https://t.co/yBgezBovt2
Onchain capital markets represent the biggest paradigm shift we are experiencing in crypto, and Nemesis is positioned to power it.
Imagine every token, created permissionlessly, being able to be longed or shorted with spot liquidity and leverage.
There is no other DEX you will need.
Nemesis.
Today we are proud to partner with @BitgetWallet, dropping 300 Nemesis Arena Tickets to its most active users.
Join the event now: https://t.co/dxC54sdFrl
This event will end in 5 days, so make sure to complete all required tasks before then.
Nemesis.
Why @BioProtocol matters 🧠
→ It manages AUM + POL
→ Liquidity is optimized
→ Fees fund long-term growth
Not just a launchpad. A funding engine for science.
Highlights and key takeaways from DeSci Singapore 2025 last week 👇
→ AI hits 70% accuracy in predicting negative chemical reactions (vs. 30% for humans). But humans still win on positives. Biggest bottleneck? No incentive to share failed experiments.
→ Longevity is at its “Ozempic moment.” Pharma is now forced to compete with its own blockbuster drugs, pushing them to take aging research seriously.
→ @RealAaronWeaver: 95% of diseases lack effective treatments. Pharma only funds $1B+ opportunities. Everything below that threshold is where DeSci thrives.
→ @Aubrai_ generated 3,000+ hypotheses in weeks via public prompting, each minted as on-chain “proof of invention” that can be funded into IP-NFTs.
→ @vitadao’s VITA-FAST project scaled from $80K community funding → $300K raise → $5–6M valuation in just 18 months. Proof that liquid IP markets work.
→ @CryptoHayes: DeSci needs commercially obvious narratives “the next Viagra” stories that traders can pitch in one sentence.
→ @Molecule_dao Protocol V2 introduces token-bound accounts letting IP-NFTs hold treasuries, data, and assets with milestone-based funding tied to on-chain proof of progress.
→ @D1ckGPT gamified medical assessments, analyzing 50,000+ cases in a week (more than most hospitals do annually). Consumer tools can power massive research datasets.
→ @dermadao: Eczema affects 600M people but gets no NIH funding (classified as “benign”). DeSci can fill these gaps and build profitable D2C health products.
Full talks here:
https://t.co/zXty6utEuD
The Arena opens for the Migglers ⚔️😼
Join the anti-heroes shaping the Internet Capital Market with @Nemesisdottrade 💰
💎 210 whitelist spots + 300 Arena Points for Miggles holders (20k+ $MIGGLES)
📸 Snapshot in 24h — claim your points + enter exclusive community draws
🏟 Enter: https://t.co/8L8wg1COYO
It's time to get Migglish 😻